Genetic factors play an important role in determining bone mass and se
veral genes probably act as regulators of this process, Interleukin-6
(IL-6) is a candidate gene for regulation of bone density, since it ha
s stimulatory effects on cells of the osteoclast lineage and has been
implicated in the pathogenesis of bone loss associated with estrogen d
eficiency, Here we studied the relationship between bone mineral densi
ty (BMD) and a polymorphic AT rich minisatelite repeat in the 3' flank
of the IL-6 gene in a cohort of 200 women, Six length variants were i
dentified (designated A-Fl, but four of these were rare such that the
vast majority of individuals fell into one of two common genotypes: F/
F (58.5%) and C/F (27.5%), There was a significant relationship betwee
n IL-6 genotype and bone mass at the lumbar spine as determined by ana
lysis of variance (p = 0.04) and a similar trend for bone mass at the
femoral neck (p = 0.11), When BMD values were compared in the two comm
on genotypes, we found that spine BMD values were significantly higher
in the C/F genotype (mean +/- SEM = 0.94 +/- 0.04 g/cm(2)) as compare
d with the F/F genotype (0.81 +/- 0.02 g/cm(2); p = 0.012). A similar
trend was seen for hip BMD values, but here, the difference failed to
reach statistical significance (p = 0.06). Further analysis showed tha
t genotype-specific effects on bone mass were observed in both premeno
pausal and postmenopausal women and did not increase with age, suggges
ting that the association between IL-6 polymorphisms and bone density
may be mediated by an effect on peak bone mass, rather than rate of bo
ne loss, We conclude that bone mass is associated with two common poly
morphisms of the IL-6 gene, Although the mechanisms that underlie this
association will require further research, our data suggest that poly
morphic variation at the IL-6 gene locus may contribute to the genetic
regulation of bone mass. (C) 1997 by Elsevier Science Inc. All rights
reserved.